Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Prevalence of maternal Rh isoimmunization in public maternity hospitals in Amazonas between 2018 and 2020
PDF (Portuguese (Brazil))

Supplementary Files

Certificado (Portuguese (Brazil))

Keywords

Rh isoimmunization
Rho(D) immunoglobulin
Prenatal care

How to Cite

Prevalence of maternal Rh isoimmunization in public maternity hospitals in Amazonas between 2018 and 2020. (2021). Electronic Journal Collection Health, 13(9), e8802. https://doi.org/10.25248/reas.e8802.2021

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To analyze the prevalence of maternal Rh isoimmunization from 2018 to 2020 in a maternity hospital in Amazonas. Methods: An observational and descriptive retrospective study of cases of maternal Rh(D) sensitization attended in a public maternity hospital in the city of Manaus, Amazonas, Brazil, was conducted. Secondary data from medical records were used to analyze variables such as blood typing and RhD factor, age, race, gestational age, parity, Coombs control tests. These medical records were catalogued in the Medical and Emergency Care Service (SAME) during the study period. Results: The prevalence was 1.49% of reported cases. The mean age of pregnant women was 25.17 years, and 63% of the patients were brown. The blood typing was 61.2% of the women were O negative and the newborns 41.5% were O positive. The mean number of prenatal visits was only 5.3. Conclusion: The prevalence rate found, although low, could be even lower, since in most women in the North Region other blood types are more prevalent. The low number of prenatal consultations may have been a factor responsible for the failure to prevent perinatal hemolytic disease in the state.

PDF (Portuguese (Brazil))